Former President and Chief Executive Officer · ABEONA THERAPEUTICS INC. (ABEO)

Michael Amoroso

A named executive officer of ABEONA THERAPEUTICS in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,064,987

Salary $450,477Stock awards $1,013,000

FY2020: $1,499,160

1st of 4 named executive officers at Abeona Therapeutics by FY2021 total.

4 named officers on file for ABEONA THERAPEUTICS, FY2021

Michael Amoroso’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ABEONA THERAPEUTICS’s whole pay program stands against its peers

  • ABEONA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABEO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed July 11, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Michael Amoroso’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Michael Amoroso compensation by year

ABEONA THERAPEUTICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as ABEONA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$219,071$450,477
Bonus$106,400$0
Stock awards$338,728$1,013,000
Option awards$827,294$1,589,910
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$7,667$11,600
Total$1,499,160$3,064,987

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ABEONA THERAPEUTICS INC. DEF 14A filed July 11, 2022, accession 0001140361-22-025707, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ABEONA THERAPEUTICS INC. filed document, accession 0001140361-22-025707. Every figure is read from that document and cited to the page and table it appears in. Filed July 11, 2022.

$1.5M
$3.1M
FY20
FY21
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU10,000$85,000—
RSU8,000$68,000—
Option16,000—$58.50
Option20,000—$54.50
Option2,916—$26.75
Option6,458—$28.75

Per the Outstanding Equity Awards at Fiscal Year-End table in ABEONA THERAPEUTICS INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

10 Form 4 lines since the FY2021 proxy (filed July 11, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-01-26Grant or award—37,313$0.00217,779
2025-01-31Grant or award—36,101$0.00180,466
2024-08-26Grant or award—11,797$0.00144,365
2024-07-08Grant or award—23,611$0.00132,568
2023-09-27Sale—5,508$3.91108,957
2023-09-20Sale—327$3.90114,465
2023-06-20Sale—338$4.45114,792
2023-06-14Grant or award—58,689$4.62115,130

The 8 most recent of 10 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

ABEONA THERAPEUTICS’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Michael Amoroso · this pageFormer President and Chief Executive Officer$3,064,987
Edward CarrFormer Chief Accounting Officer and Chief Financial Officer$1,569,879
Vishwas SeshadriPresident and Chief Executive Officer$1,566,475
Brendan O’MalleyGeneral Counsel$1,179,209

Board service

ABEONA THERAPEUTICS board · FY2021–FY2025
Director compensation in US dollars, as ABEONA THERAPEUTICS reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$85,000$200,000—$0$285,000
FY2024$80,000$181,048—$0$261,048
FY2023$80,000$271,143—$0$351,143
FY2022$80,000$37,386——$117,386
FY2021$0$0$0——

Each year as the company reported it in ABEONA THERAPEUTICS's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: ABEONA THERAPEUTICS pays directors a $50,000 cash retainer and $200,000 in Restricted Stock. As stated in ABEONA THERAPEUTICS's FY2025 proxy.

Committees

Nominating/Governance

The full ABEONA THERAPEUTICS compensation record

free company brief

This page is one person within ABEONA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ABEONA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Amoroso's compensation dossier · One-time report. No refunds.